Eaton Vance Management’s GoodRx Holdings GDRX Stock Holding History

Eaton Vance Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29,506	Closed	-$570K	–	1669
2022 Q1	$570K	Buy	29,506 +29,480	+113,385%	+$676K	﹤0.01%	1492
2021 Q4	$1K	Sell	26 -50	-66%	-$2.01K	﹤0.01%	2774
2021 Q3	$0	Buy	+76	New	+$2.76K	﹤0.01%	2276

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Eaton Vance Management's GDRX Position: Q2 2022 in Review

Eaton Vance Management sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 29,506 shares — an estimated $570K sold.

Eaton Vance Management first reported a position in GDRX in Q3 2021 and held it in 3 quarters. The position peaked at $570K in Q1 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

Eaton Vance Management reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
Eaton Vance Management sold 29,506 GoodRx Holdings shares in Q2 2022, an estimated $570K.
Eaton Vance Management first reported a position in GoodRx Holdings in Q3 2021 and held it in 3 quarters.
Eaton Vance Management's GoodRx Holdings position peaked at $570K in Q1 2022.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Eaton Vance Management's 13F filing for Q2 2022, filed 15 Aug 2022.